US EditionMedline Announces Public Filing of Registration Statement with the SEC
Medline aims to raise $5 billion in its IPO to fund growth, reduce debt, and provide liquidity, potentially making it the largest U.S. offering this year, Bloomberg reported.
- On Oct. 28, 2025, Medline Inc., Northfield, Illinois publicly filed a Form S-1 registration statement for a proposed IPO, though the registration is not yet effective and share details remain unspecified.
- Having filed a draft in June 28, Medline follows a June 2021 sale to funds managed by Blackstone Group, Carlyle Group, and Hellman & Friedman.
- Bloomberg reported the potential $5 billion raise and $50 billion valuation, and Medline plans to list on the Nasdaq Global Select Market under MDLN with Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan Securities LLC as lead bookrunners.
- Regulatory steps require Medline to wait at least 15 days before investor road shows, and after SEC comments are resolved the company can request effectiveness, set share pricing, and begin trading.
- Known for items like the pink and blue striped newborn blanket, Medline employs over 43,000 people and reported $13.5 billion in net sales for six months ended June 28, and Bloomberg reported it could be the biggest U.S. IPO this year if completed before Dec. 31.
23 Articles
23 Articles
Northfield-based Medline files for proposed initial public offering
Medline – a massive medical supply company based in Northfield – publicly filed paperwork Tuesday for a proposed initial public offering. The registration statement filed with the U.S. Securities and Exchange Commission does not say how many shares will be sold or at what prices, but it is a step toward taking the company public. Bloomberg previously reported that the company was seeking an initial public offering that would raise about $5 billi…
Medline Announces Public Filing of Registration Statement with the SEC
NORTHFIELD, Ill., Oct. 28, 2025 /PRNewswire/ -- Medline Inc. announced today that it has publicly filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of its common…
Medline Files For IPO, Aims for Triumphant Return to Public Markets
Medical supplies powerhouse Medline Industries Inc. has officially filed for an initial public offering (IPO), signaling its return to the public market four years after a $30 billion private equity buyout by Blackstone, Carlyle Group, and Hellman & Friedman. The long-anticipated filing — prepared with Simpson Thacher & Bartlett LLP as company counsel and Latham Medline Files For IPO, marking its return to public markets after a $30B private equi
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
